LifePoint Hospitals Inc. announced unaudited consolidated earnings results for third quarter and nine months ended September 30, 2017. For the quarter, revenues were $1,576 million against $1,585.7 million a year ago. Income before income taxes was $55.2 million against $64.9 million a year ago. Net income attributable to the company was $27.5 million or $0.67 per diluted share against $39.5 million or $0.92 per diluted share a year ago. Net cash provided by operating activities was $91.1 million against $177.6 million a year ago. Purchases of property and equipment were $108.5 million against $103.4 million a year ago. Adjusted EBITDA was $176 million against $188 million a year ago. Diluted earnings per share as adjusted were $0.80, down $0.12 compared to $0.92 in the same quarter of the prior year.

For the nine months, revenues were $4,801 million against $4,758.8 million a year ago. Income before income taxes was $221.6 million against $131.9 million a year ago. Net income attributable to the company was $129.9 million or $3.16 per diluted share against $78 million or $1.78 per diluted share a year ago. Net cash provided by operating activities was $293.4 million against $332.7 million a year ago. Purchases of property and equipment were $266.2 million against $226.3 million a year ago. Adjusted EBITDA was $563.8 million against $525 million a year ago.

The company provided revised earnings guidance for the year 2017. For the period, the company expected net revenue is to be in between $6.335 billion to $6.385 billion. Adjusted EBITDA is expected to be in between $740 to $760 million. Adjusted diluted EPS is expected to be in between $3.48 to $3.78. Net income expected to be in between $154.4 million to $167.4 million. Net income attributable to company expected to be in between $142.4 million to 154.4 million. Capital expenditures are expected to be in the range of $475 million to $500 million. The company expects Interest expense, net of $149.7 million.

The company recognized an impairment charge during the quarter of $12.7 million or $0.33 loss per diluted share related to the divestiture of Rockdale Medical Center.

For the fourth quarter 2017, at the midpoint of guidance, the company sees total revenue decline on a same-store basis at 0.9%.